Effect of Intrathecal vs Intraarticular Dexmedetomidine on Postoperative Pain Following Arthroscopy
NCT ID: NCT02581566
Last Updated: 2019-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2015-07-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine,Ketamine and Their Combination to Bupivicaine on Thoracic Epidural Analgesia
NCT03063671
Effect of Intrathecal Morphine, Dexmedetomidine or Both in Combination to Bupivacaine on Immunity
NCT03024957
Fentanyl vs Dexmedetomidine for Arthriscopic Shoulder Intervention in Elderly.
NCT05577117
Preemptive Oral Gabapentin and Tramadol on Postoperative Pain After Knee Arthroscopy
NCT06112223
Intrathecal Morphine Versus Morphine-dexmedetomidine Combination for Postoperative Pain Control After Total Knee Replacement
NCT05439564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intrathecal Dexmedetomidine Group
30 patients will be given Intrathecal Dexmedetomidine plus Intrathecal Bupivacaine
Intrathecal Dexmedetomidine
Addition of Intathecal Dexmedetomidine plus Intrathecal Bupivacaine
Intraarticular Dexmedetomidine Group
30 patients will be given Intraarticular Dexmedetomidine plus Intrathecal Bupivacaine
Intraarticular Dexmedetomidine
Addition of Intraarticular Dexmedetomidine plus Intrathecal Bupivacaine
control Group
30 patients will be given Intrathecal Bupivacaine
Bupivacaine
Intrathecal Bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrathecal Dexmedetomidine
Addition of Intathecal Dexmedetomidine plus Intrathecal Bupivacaine
Intraarticular Dexmedetomidine
Addition of Intraarticular Dexmedetomidine plus Intrathecal Bupivacaine
Bupivacaine
Intrathecal Bupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman A. Ismail
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01003060215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.